Pharma and life sciences

Build useful communication inside a regulated evidence system

We help teams connect market understanding, stakeholder needs, approved claims, content operations and digital journeys while keeping promotional and non-promotional purposes distinct.

01

What should change

A defined communication purpose

Each asset has an audience, decision, approved evidence base and clear promotional or educational status.

Less content fragmentation

Web, field, professional and patient materials use consistent language and a governed source of claims.

A measurable digital journey

Teams can see whether content reaches the intended audience and supports the next appropriate action.

02

What the engagement includes

01

Market and stakeholder insight

Patient, caregiver, professional, payer, partner and internal perspectives relevant to the programme.

02

Positioning and message architecture

Audience needs, role of the brand or programme, claim hierarchy, evidence and required qualification.

03

Digital experience

Websites, portals and content journeys designed around audience eligibility, purpose and appropriate access.

04

Content operations

Briefs, references, versioning, review workflow, expiry and reuse across markets or channels.

05

Professional and patient communication

Distinct information needs, literacy levels, risk context and calls to action for each audience.

06

Measurement design

Engagement and progression measures that respect consent, audience restrictions and sensitive-data requirements.

03

How the work runs

Define the market context

Clarify country, audience, product status, programme purpose and approval requirements.

Build the evidence and message map

Connect each communication objective to approved source material and ownership.

Design the experience

Create the smallest useful set of journeys and assets for the target audiences.

Govern and improve

Use review outcomes and audience behaviour to improve clarity without bypassing approval.

04

How decisions are made

Demand evidence

We examine what people search for, the questions they ask and the alternatives they compare. Internal assumptions are useful hypotheses, not substitutes for demand evidence.

Operational reality

Service mix, clinician capacity, locations, lead times, economics and referral patterns shape the plan. Marketing should not create demand the organisation cannot serve well.

The full conversion path

We look beyond the channel to the landing page, evidence, enquiry route, call handling, scheduling and the reasons people do not proceed.

Responsible communication

Clinical and product claims require substantiation and jurisdiction-specific review. Measurement and tracking choices must be appropriate for sensitive health data.

05

How success is assessed

The measurement plan depends on the business model, but it does not end with traffic, impressions or submitted forms.

  • Reach within the intended and permitted audience
  • Engagement with priority evidence and service information
  • Progression to an appropriate professional or programme action
  • Content approval time and revision volume
  • Reuse, freshness and retirement of governed assets
  • Consent, access and data-quality controls

Connected capabilities

When the problem is wider than one channel

Research

Understand stakeholder needs, language and decision barriers.

Explore →

Healthcare content

Create an editorial system with clear evidence and review ownership.

Explore →

Healthtech

Position complex products around evidence, workflow and adoption.

Explore →

Let’s define the first useful move

Tell us about the organisation, the priority service line and the outcome that needs to change.

Email Supermed